10x Genomics Stock Volume Indicators On Balance Volume
| TXG Stock | USD 18.12 0.61 3.48% |
| Symbol |
Indicator |
The output start index for this execution was zero with a total number of output elements of sixty-one. The On Balance Volume indicator was developed by Joe Granville to show time series momentum that relates 10X Genomics volume to price change. It can show when 10X Genomics is accumulated or sold by a large number of investors.
10X Genomics Technical Analysis Modules
Most technical analysis of 10X Genomics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for 10X from various momentum indicators to cycle indicators. When you analyze 10X charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About 10X Genomics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of 10X Genomics. We use our internally-developed statistical techniques to arrive at the intrinsic value of 10X Genomics based on widely used predictive technical indicators. In general, we focus on analyzing 10X Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build 10X Genomics's daily price indicators and compare them against related drivers, such as volume indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of 10X Genomics's intrinsic value. In addition to deriving basic predictive indicators for 10X Genomics, we also check how macroeconomic factors affect 10X Genomics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 13.31 | 15.21 | 15.62 | 16.41 | Days Of Inventory On Hand | 128.47 | 154.53 | 103.37 | 131.91 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 10X Genomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 10X Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median. For more detail on how to invest in 10X Stock please use our How to Invest in 10X Genomics guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Can Life Sciences Tools & Services industry sustain growth momentum? Does 10X have expansion opportunities? Factors like these will boost the valuation of 10X Genomics. If investors know 10X will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating 10X Genomics demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (0.35) | Revenue Per Share | Quarterly Revenue Growth (0.02) | Return On Assets | Return On Equity |
The market value of 10X Genomics is measured differently than its book value, which is the value of 10X that is recorded on the company's balance sheet. Investors also form their own opinion of 10X Genomics' value that differs from its market value or its book value, called intrinsic value, which is 10X Genomics' true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because 10X Genomics' market value can be influenced by many factors that don't directly affect 10X Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 10X Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if 10X Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, 10X Genomics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.